OTCMKTS:MYDP - Dougherty's Pharmacy Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.10 0.00 (0.00 %) (As of 03/20/2019 03:52 AM ET)Previous Close$0.10Today's Range$0.10 - $0.1052-Week Range$0.0137 - $0.20VolumeN/AAverage Volume32,071 shsMarket Capitalization$2.31 millionP/E RatioN/ADividend YieldN/ABeta8.59 ProfileDiscussionChartEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Dougherty's Pharmacy, Inc., an investment firm, focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty's Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty's Pharmacy, Inc. in May 2017. Dougherty's Pharmacy, Inc. was founded in 1998 and is based in Dallas, Texas. Receive MYDP News and Ratings via Email Sign-up to receive the latest news and ratings for MYDP and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug stores & proprietary stores Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:MYDP Previous Symbol CUSIPN/A CIK1080029 Webwww.izea.com Phone972-250-0945Debt Debt-to-Equity Ratio2.74 Current Ratio0.67 Quick Ratio0.27Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$40.21 million Price / Sales0.06 Cash FlowN/A Price / Cash FlowN/A Book Value$0.07 per share Price / Book1.43Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-2,100,000.00 Net Margins-6.05% Return on Equity-79.29% Return on Assets-10.64%Miscellaneous EmployeesN/A Outstanding Shares23,100,000Market Cap$2.31 million Next Earnings Date4/4/2019 (Estimated) OptionableNot Optionable Dougherty's Pharmacy (OTCMKTS:MYDP) Frequently Asked Questions What is Dougherty's Pharmacy's stock symbol? Dougherty's Pharmacy trades on the OTCMKTS under the ticker symbol "MYDP." How were Dougherty's Pharmacy's earnings last quarter? Dougherty's Pharmacy Inc (OTCMKTS:MYDP) released its earnings results on Tuesday, August, 14th. The company reported ($0.02) earnings per share for the quarter. The company had revenue of $9.17 million for the quarter. Dougherty's Pharmacy had a negative net margin of 6.05% and a negative return on equity of 79.29%. View Dougherty's Pharmacy's Earnings History. When is Dougherty's Pharmacy's next earnings date? Dougherty's Pharmacy is scheduled to release their next quarterly earnings announcement on Thursday, April 4th 2019. View Earnings Estimates for Dougherty's Pharmacy. Has Dougherty's Pharmacy been receiving favorable news coverage? Media coverage about MYDP stock has trended negative this week, according to InfoTrie. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Dougherty's Pharmacy earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. Who are some of Dougherty's Pharmacy's key competitors? Some companies that are related to Dougherty's Pharmacy include CVS Health (CVS), Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Covetrus (CVET), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Diplomat Pharmacy (DPLO), Taxus Pharmaceuticals (TXSP) and HealthWarehouse.com (HEWA). What other stocks do shareholders of Dougherty's Pharmacy own? Based on aggregate information from My MarketBeat watchlists, some companies that other Dougherty's Pharmacy investors own include Floor & Decor (FND), National Vision (EYE), Zynerba Pharmaceuticals (ZYNE), Armstrong World Industries (AWI), Bristol-Myers Squibb (BMY), Toronto-Dominion Bank (TD), Honda Motor (HMC), Alibaba Group (BABA), Intuit (INTU) and Century Casinos (CNTY). Who are Dougherty's Pharmacy's key executives? Dougherty's Pharmacy's management team includes the folowing people: Mr. James C. Leslie CPA, CPA, Chairman, Interim Pres, Interim CFO & Sec. (Age 64)Ms. Katherine Burrow, Managing Director of Bus. Devel.Ms. Susan K. Olson, Sec.Ms. Robin Bruce, ControllerMr. Rick Troberman, Exec. VP of Sales and Marketing How do I buy shares of Dougherty's Pharmacy? Shares of MYDP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Dougherty's Pharmacy's stock price today? One share of MYDP stock can currently be purchased for approximately $0.10. How big of a company is Dougherty's Pharmacy? Dougherty's Pharmacy has a market capitalization of $2.31 million and generates $40.21 million in revenue each year. What is Dougherty's Pharmacy's official website? The official website for Dougherty's Pharmacy is http://www.izea.com. How can I contact Dougherty's Pharmacy? Dougherty's Pharmacy's mailing address is 5924 ROYAL LANE SUITE 250, DALLAS TX, 75230. The company can be reached via phone at 972-250-0945 or via email at [email protected] MarketBeat Community Rating for Dougherty's Pharmacy (OTCMKTS MYDP)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 128 (Vote Outperform)Underperform Votes: 148 (Vote Underperform)Total Votes: 276MarketBeat's community ratings are surveys of what our community members think about Dougherty's Pharmacy and other stocks. Vote "Outperform" if you believe MYDP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYDP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/20/2019 by MarketBeat.com StaffFeatured Article: What are the components of an earnings report?